Generic Name:

Leuprolide Acetate

Storage Condition:

2°C TO 8°C Temperature

Packing:

1 Vial

Mfg / Mkd By:

Emcure pharmaceutical

Doses:


Therapeutic Use:

Prostatic cancer

Description:

Introduction of ELIGARD
22.5MG INJECTION
:

ELIGARD 22.5MG
INJECTION contains Leuprolide which belongs to the group of medicines called
Gonadotropin Releasing Hormone (GnRH) Agonist. It is used for palliative
management (relieving symptoms and minimising the associated suffering) of
advanced prostatic cancer. Advanced prostatic cancer is a cancer (abnormal cell
multiplication and differentiation) that originates in the prostate gland and
spreads to the other parts of the body. It is characterized by the symptoms
such as painful urination, decreased urine pressure, blood in the semen, bone
pain, leg swelling, and weakness.

Do not receive
ELIGARD 22.5MG INJECTION if you are allergic to Leuprolide, GnRH, GnRH agonist
analogs. Before receiving the medicine, inform your doctor if you have liver
impairment, kidney impairment, congenital long QT syndrome, congestive heart
failure, frequent electrolyte abnormalities, metastatic vertebral lesions,
urinary tract obstruction, or diabetes. Before receiving this medicine, inform
your doctor if you have a history of seizures, epilepsy, cerebrovascular
disorders, or central nervous system anomalies/tumours. ELIGARD 22.5MG
INJECTION is not recommended for use in pregnant women, breastfeeding women,
and children.

It should be used
with caution in elderly patients (aged above 65 years). Consult your doctor
before receiving. The most common side effects associated with the use of
ELIGARD 22.5MG INJECTION are general pain, reactions at the site of injection,
hot flashes/sweating, gastrointestinal disorders, joint disorders, shrinking of
testes, urinary disorders, infections in upper respiratory tract, and fatigue.
Consult your doctor if any of these side effects worsens.

Uses of ELIGARD 22.5MG INJECTION:

·
Used
for palliative management (relieving symptoms and minimize the associated
suffering) of advanced prostatic cancer

How to use ELIGARD 22.5MG INJECTION:

ELIGARD 22.5MG
INJECTION will be administered to you only by a doctor or a nurse
intramuscularly (into the muscle) or subcutaneously (under the skin). Your
doctor will administer the correct dose and duration for you depending upon
your age, body weight and disease condition.

Our Other Products

View All
Carboplatin

Carboplatin

Generic Name: Carboplatin

Injection
Packaging:45 ml vial
Mfg / Mfd By:Pfizer Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Cancer
Bdnab (Paclitaxel)

Bdnab (Paclitaxel) 100 mg

Generic Name: Paclitaxel

Injection
Packaging:1 Vial
Mfg / Mfd By:Bdr pharmaceutical
Storage Condition:Store in a refrigerator (2° - 8°C). Do not freeze.
Therapeutic Use:
Breast cancer Ovarian cancer
Bdocin (Capecitabine)

Bdocin (Capecitabine) 500 mg

Generic Name: Capecitabine

Tablet
Packaging:12 X 10 Tablets
Mfg / Mfd By:BDR Pharmaceuticals Internationals Pvt Ltd
Storage Condition:Store below 25°C
Therapeutic Use:
Cancer
Bdparp (Olaparib)

Bdparp (Olaparib) 150 mg

Generic Name: Olaparib

Tablet
Packaging:28 Tablets
Mfg / Mfd By:Bdr pharmaceutical
Storage Condition:Store below 30°C
Therapeutic Use:
Brest cancer